comparemela.com

Latest Breaking News On - Aeglea biotherapeutics inc - Page 21 : comparemela.com

Research Analysts New Coverage for April 19th (AAWW, ADES, ADMP, ADXS, AGFS, AGLE, AIMC, AJRD, AKAM, APA)

Research Analysts’ new coverage for Wednesday, April 19th: StockNews.com began coverage on shares of Atlas Air Worldwide (NASDAQ:AAWW). The firm issued a hold rating on the stock. StockNews.com initiated coverage on shares of Advanced Emissions Solutions (NASDAQ:ADES). StockNews.com issued a hold rating on the stock. StockNews.com initiated coverage on shares of Adamis Pharmaceuticals (NASDAQ:ADMP). They […]

Aeglea BioTherapeutics (NASDAQ:AGLE) Rating Lowered to Market Perform at Lifesci Capital

Lifesci Capital cut shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) from an outperform rating to a market perform rating in a research report sent to investors on Wednesday morning, MarketBeat reports. A number of other research analysts have also issued reports on the company. HC Wainwright reissued a neutral rating and issued a $1.00 […]

Aeglea BioTherapeutics (NASDAQ:AGLE) Receives Hold Rating from Jonestrading

Jonestrading reaffirmed their hold rating on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a report released on Wednesday morning, Benzinga reports. AGLE has been the topic of several other reports. Wells Fargo & Company lowered shares of Aeglea BioTherapeutics from an overweight rating to an equal weight rating in a report on Wednesday. […]

Aeglea BioTherapeutics (NASDAQ:AGLE) Cut to Market Perform at Lifesci Capital

Lifesci Capital lowered shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) from an outperform rating to a market perform rating in a report released on Wednesday morning, Marketbeat.com reports. Other research analysts have also recently issued research reports about the stock. Wells Fargo & Company cut shares of Aeglea BioTherapeutics from an overweight rating to […]

Aeglea BioTherapeutics (NASDAQ:AGLE) Research Coverage Started at StockNews com

StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a research report released on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a neutral rating and issued a $1.00 target price on shares of Aeglea BioTherapeutics in a report on Friday, March 3rd. […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.